recombin
fab
recogn
neutral
epitop
locat
region
protein
e
dengu
viru
obtain
clone
hybridoma
cell
secret
mous
monoclon
antibodi
mab
fd
light
chain
antibodi
gene
amplifi
polymeras
chain
reaction
clone
phagemid
vector
pmad
express
bacteria
produc
fab
fragment
sequenc
mab
particular
light
chain
complementarydetermin
region
share
homolog
two
antivir
mab
affin
parent
mab
clone
fab
male
fusion
protein
shown
magnitud
ie
nanomolar
fab
neutral
capac
found
less
lower
mab
depend
serotyp
thu
fab
could
smaller
antivir
activ
mab
vitro
dengu
viru
member
famili
viru
caus
diseas
preval
north
south
parallel
incid
estim
million
per
year
caus
death
tolou
et
al
appear
hyper
endem
transmiss
america
gubler
transmit
among
human
mosquito
mainli
aed
aegypti
wide
spectrum
symptom
encount
rang
benign
fever
occasion
hemorrhag
potenti
fatal
syndrom
without
medic
intervent
case
fatal
rate
hemorrhag
shock
syndrom
reach
igarashi
mechan
syndrom
still
discuss
specif
strain
could
involv
murgu
et
al
ii
preexist
subneutr
antibodi
could
enhanc
antibodymedi
uptak
viru
monocyt
macrophag
design
host
cell
viru
antibodi
depend
enhanc
ade
hawk
lafferti
see
review
porterfield
requir
fc
region
igg
ade
demonstr
halstead
orourk
compar
whole
human
serum
enhanc
activ
fab
origin
requir
fonction
fcg
receptor
ade
also
shown
littaua
et
al
receptor
present
surfac
macrophag
play
major
role
phagocytosi
antibodyco
particl
paul
depend
fc
bind
igg
specif
prophylact
therapeut
agent
current
avail
dengu
diseas
intraven
infus
correct
hypovolemia
eventu
blood
transfus
reduc
mortal
rate
monoclon
antibodi
passiv
transfer
mice
challeng
lethal
intracerebr
dose
dengu
viru
shown
protect
kaufman
et
al
case
anoth
viru
vesicular
stomat
viru
protect
lethal
infect
shown
mediat
neutral
antibodi
zinkernagel
immunotherapi
dengu
prophylaxi
treatment
could
thu
interest
igg
fragment
lack
fc
scfv
fab
use
particip
enhanc
effect
ade
work
fab
prefer
scfv
better
stabil
result
longer
halflif
fab
recent
shown
greater
halflif
correspond
scfv
lamarr
et
al
recombin
igg
fragment
alreadi
obtain
influenza
viru
caton
koprowski
stark
caton
hiv
viru
rabi
viru
cheung
et
al
muller
et
al
respiratori
synciti
viru
tempest
et
al
hepat
b
viru
hantaan
viru
liang
et
al
coronaviru
lamarr
talbot
flavivirus
loop
ill
tickborn
enceph
jiang
et
al
dengu
viru
studi
clone
phagemid
vector
fab
region
murin
monoclon
antibodi
mab
rais
dengu
viru
immunochem
serolog
properti
mab
fab
compar
hybridoma
cell
produc
murin
monoclon
antibodi
recogn
dengu
viru
serotyp
envelop
protein
prepar
accord
protocol
publish
previous
moren
et
al
cell
gener
gift
dr
dm
moren
mab
k
isotyp
protect
vivo
dengu
viru
serotyp
mg
protect
weeksold
balbc
mice
challeng
dl
data
shown
total
rna
isol
cell
mous
hybridoma
rnaxel
eurobio
le
uli
franc
cdna
synthet
use
random
hexanucleotid
lafay
et
al
mlv
enzym
eurobio
pcramplifi
saiki
et
al
pcr
primer
harbour
restrict
site
enabl
doublestrand
pcr
product
clone
vector
primer
design
hybrid
partial
conserv
sequenc
code
nterminu
variabl
region
four
primer
light
chain
eight
primer
fd
test
depend
famili
belong
templat
primer
hybrid
region
correspond
light
chain
cterminu
hing
region
fd
pcr
condit
describ
elsewher
lafay
et
al
digest
saci
xbai
gibco
gaithersburg
md
light
chain
gene
clone
phagemid
express
vector
pmad
kindli
given
us
g
orfanoudaki
esb
strasbourg
digest
xhoi
spei
boehring
mannheim
germani
fd
gene
clone
frame
gene
minor
coat
protein
iii
piii
filament
phage
vector
alreadi
receiv
light
chain
gene
schemat
draw
construct
see
barba
et
al
phagemid
introduc
compet
e
coli
cell
cacl
transform
sambrook
et
al
effici
rate
transform
per
mg
phagemid
phagefab
obtain
describ
elsewher
lafay
et
al
titrat
parmley
smith
analys
elisa
describ
select
phagemid
digest
nhei
spei
boehring
remov
gene
code
piii
ligat
transform
clone
cultiv
od
reach
iptg
ad
concentr
mm
cultur
grown
overnight
stir
cell
pellet
centrifug
solubl
fab
recov
periplasm
osmot
shock
one
ml
buffer
g
saccharos
ml
edta
ph
ml
tri
ph
milliq
purifi
water
total
volum
ml
use
extract
fab
express
ml
cultur
periplasm
fraction
clear
centrifug
g
min
fab
purifi
affin
column
prepar
coval
coupl
antimous
fab
antibodi
sigma
st
loui
mo
protein
gsepharos
sigma
mm
dimethylpimelimid
sigma
harlow
lane
fab
elut
mm
glycin
ph
neutral
ad
trishcl
ph
dialys
agaist
pb
filter
millexgp
mm
millipor
bedford
protein
e
fragment
dengu
viru
strain
et
al
locat
residu
e
clone
male
fusion
protein
pmalc
plasmid
biolab
beverli
follow
procedur
describ
previous
megret
et
al
protein
produc
e
coli
purifi
maltodextrin
column
accord
manufactur
procedur
biolab
protein
concentr
mg
ml
pb
coat
h
microtit
plate
nunc
roskild
denmark
plate
wash
six
time
pb
tween
pgt
non
specif
bind
block
h
pgt
twofold
dilut
ml
phagefab
start
transform
unit
per
ml
distribut
well
neg
control
non
recombin
phage
h
plate
wash
well
incub
ml
antiphag
hors
radish
peroxydas
hrp
conjug
pharmacia
uppsala
sweden
reveal
orthophenylenediamin
dihydrochlorid
dako
glostrup
denmark
nm
absorb
measur
elisa
reader
dynatech
guernsey
concentr
solubl
fab
periplasm
extract
elisa
assay
use
rat
antimous
chain
immunotech
marseil
franc
coat
goat
antimous
fab
hrp
conjug
sigma
revel
result
establish
comparison
purifi
recombin
fab
affin
measur
solut
friguet
et
al
sampl
fab
periplasm
extract
dilut
pgt
mab
ng
ml
incub
overnight
increas
amount
male
concentr
rang
remain
free
antigenbind
site
quantifi
elisa
use
antimous
bgalactosidas
conjug
j
gregoir
pasteur
institut
pari
bd
galactosid
sigma
fluoresc
read
fluoroskan
labsystem
finland
nm
excit
nm
automat
sequenc
perform
genom
express
sa
grenobl
franc
use
gcc
gct
gga
ttg
tta
tta
ctc
cac
cct
cag
agc
cac
cac
cct
fd
sequenc
kef
gaa
ttc
taa
act
agc
tag
tcg
univers
primer
tga
ccg
gca
gca
aaa
tg
light
chain
sequenc
dna
sequenc
genbankembl
nucleotid
sequenc
data
base
compar
use
genet
comput
group
softwar
univers
wisconsin
wi
dna
sequenc
fab
heavi
light
chain
access
genbank
follow
number
respect
neutral
test
perform
vero
cell
cultur
plate
prototyp
dengu
virus
four
serotyp
dengu
viru
strain
follow
hawaii
serotyp
new
guinea
c
serotyp
h
serotyp
h
serotyp
periplasm
extract
contain
fab
periplasm
extract
nontransform
purifi
fab
store
parent
mab
store
high
concentr
incub
twofold
serial
dilut
focu
form
unit
ffu
viru
overnight
et
al
mixtur
incub
duplic
vero
cell
h
iscovcarboxycellulos
reincub
co
incub
day
serotyp
day
serotyp
fixat
plaqu
reveal
antidengu
viru
specif
hyperimmun
mous
ascit
fluid
antimous
hrp
conjug
neutral
capac
estim
mab
fab
concentr
caus
reduct
ffu
work
start
murin
hybridoma
prepar
recombin
fab
compar
properti
parent
mab
mrna
extract
cultur
hybridoma
cell
util
templat
rtpcr
obtain
cdna
primer
ckdna
primer
allow
amplif
dna
fragment
length
bp
size
dna
fragment
code
light
chain
primer
primer
vhiic
allow
amplif
dna
code
fd
dna
fragment
code
light
chain
insert
first
pmad
phagemid
vector
fragment
code
heavi
chain
one
clone
construct
light
chain
fd
gene
elisa
test
bind
male
fusion
protein
compar
phage
incorpor
heterolog
gene
signal
obtain
phagefab
constantli
neg
phage
linearli
depend
phagefab
concentr
data
shown
solubl
fab
product
gene
code
minor
coat
protein
iii
remov
nhei
spei
digest
compar
data
base
fd
belong
famili
consist
four
member
moncharmont
et
al
ident
share
roccaserra
et
al
roth
et
al
tillman
et
al
antibodi
direct
oestrogen
receptor
hapten
gat
dna
segment
fd
correspond
genet
element
junction
segment
correspond
genet
element
sequenc
light
chain
belong
vk
group
iii
subgroup
compar
sequenc
light
chain
code
gene
two
three
gene
present
homolog
antivir
igg
non
antivir
igg
direct
cd
ident
antivir
igg
direct
influenza
viru
stark
caton
ident
hantaan
viru
liang
et
al
ident
ident
cdr
respect
third
light
chain
cdr
play
signific
role
antigen
recognit
conserv
six
nine
residu
noteworthi
ident
fd
igg
less
remarqu
though
cdr
ident
fine
map
epitop
could
provid
clue
test
hypothesi
use
variant
light
chain
among
three
antivir
antibodi
could
eventu
signal
presenc
compar
epitop
surfac
three
differ
virus
affin
mab
fab
male
bind
respect
measur
consid
equival
due
experiment
variat
precis
method
fab
harvest
periplasm
extract
purifi
electrophores
sdspage
gel
two
narrowli
separ
band
approxim
kd
shown
correspond
light
chain
fd
present
similar
quantiti
fig
contamin
present
concentr
measur
mg
ml
bradford
method
titer
shown
concentr
mab
fab
give
reduct
number
ffu
titer
could
determin
nd
util
purifi
fab
serotyp
concentr
prepar
mg
ml
low
prnt
inhibit
perform
four
serotyp
experi
order
allow
comparison
made
fab
purifi
fab
fab
periplasm
extract
mab
serotyp
experi
preced
preliminari
experi
whose
result
accord
given
tabl
data
shown
mab
concentr
neutral
serotyp
mg
ml
fig
lower
neutral
serotyp
mg
ml
serotyp
mg
ml
tabl
periplasm
extract
without
fab
show
neutral
properti
fab
neutral
capac
could
estim
time
serotyp
four
time
serotyp
four
time
less
serotyp
lower
mab
despit
experiment
variat
observ
test
serotyp
reduct
fab
neutral
capac
compar
parent
mab
observ
alreadi
report
neutral
fab
usual
reduc
least
one
order
magnitud
compar
parent
igg
schofield
et
al
observ
reduct
agreement
conserv
affin
technic
reason
appear
loss
activ
alter
freezethaw
defect
associ
light
chain
fd
could
rule
despit
taken
precaut
reason
would
hamper
affin
measur
depend
quantiti
activ
fab
present
test
solut
linear
signal
respect
dilut
reason
base
mechan
neutral
could
also
propos
fab
bound
envelop
protein
viru
block
attach
viru
host
cell
bind
close
attach
site
see
review
dimmock
block
could
less
complet
fab
mab
due
reduct
fab
steric
hindranc
effector
fc
present
vitro
neutral
essay
fact
lack
fc
seem
caus
reduct
neutral
properti
mostli
explain
reduct
fab
steric
hindranc
vitro
neutral
experi
recombin
fab
prove
fc
diva
fig
prnt
dengu
viru
periplasm
extract
contain
fab
purifi
fab
purifi
mab
dilut
initi
concentr
indic
test
realiz
duplic
lenc
parent
mab
necessari
neutral
process
result
alreadi
establish
fab
obtain
papain
digest
could
subject
caution
due
incomplet
digest
dimmock
result
generalis
monoclon
antibodi
ubol
et
al
medic
perspect
work
could
done
improv
product
fab
test
vivo
human
fab
search
antibodi
similar
properti
human
origin
would
better
toler
medic
use
also
pursu
recent
avail
medic
practic
recombin
mousehuman
chimera
fab
abciximab
use
antiaggreg
give
ground
hope
longpursu
antivir
seroprophylaxi
serotherapi
may
day
becom
realiti
